Al Murshidi launches first Middle East branch of Insparya at Oman International Hospital
Under the distinguished auspices of Abdulsalam bin Mohammed al Murshidi, Chairman of Oman Investment Authority (OIA), the Insparya Hair Transplant Clinical Group, co-founded by renowned footballer Cristiano Ronaldo, has officially launched its first Middle Eastern branch at Oman International Hospital in Muscat.
This groundbreaking facility marks the 13th global location for Insparya and signifies its debut in the Middle East, following successful establishments in Portugal, Spain and Italy.
The inauguration ceremony was graced by esteemed guests, including Amal bint Suhail Bahwan, Chairperson of Al Afia Healthcare Development and Investment Company, and Vice Chairperson of Suhail Bahwan Group Holding, as well as other dignitaries and experts from the health sector.
Al Murshidi highlighted the strategic choice of Oman as the first country in the Middle East to host an Insparya branch, underscoring the Sultanate of Oman’s commitment to improving its healthcare sector in line with the Oman Vision 2040. He emphasised the project’s significance in attracting private investment and promoting technological advancements in healthcare services.
Amal bint Suhail Bahwan conveyed her excitement about the collaboration with Insparya Group, acknowledging the considerable enhancement it brings to Oman’s healthcare offerings. The new centre not only elevates local healthcare services to international standards but also boosts the Sultanate of Oman’s medical tourism sector.
Sandro Cardoso, Global Executive Board Member of Marketing and Commerce at Insparya Group, shared the Group’s ambitious goal of redefining industry standards on a global scale. The Insparya branch in Oman is outfitted with cutting-edge hair transplant technology, including the
Bothair Ultraplus Insparya, showcasing the Group’s dedication to innovation and excellence.
Dr Carlos Portinha, Chief Clinical Officer of Insparya Group, outlined the group’s integration of AI, advanced biomedical research, and robotics to enhance hair transplant effectiveness and patient outcomes. He reiterated Insparya’s commitment to establishing a new benchmark in hair care innovation.
Additionally, Marcelo Pereira, CEO of Oman International Hospital, commended the facility for its contribution to national healthcare by alleviating the strain on public services, offering world-class treatments, and facilities.
The expansion of the Insparya Group into the Middle East through Oman International Hospital represents a significant milestone in global healthcare innovation, promising improved access to top-quality hair transplant services for residents across the GCC and Arab nations.